Detalhe da pesquisa
1.
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
Aesthet Surg J
; 38(9): 998-1010, 2018 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29401213
2.
ATX-101 for reduction of submental fat: A phase III randomized controlled trial.
J Am Acad Dermatol
; 75(4): 788-797.e7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430612
3.
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction.
Dermatol Surg
; 42(1): 38-49, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673433
4.
Overview of ATX-101 (Deoxycholic Acid Injection): A Nonsurgical Approach for Reduction of Submental Fat.
Dermatol Surg
; 42 Suppl 1: S263-S270, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787266
5.
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.
Dermatol Surg
; 42 Suppl 1: S288-S299, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787269
6.
A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring.
J Drugs Dermatol
; 14(3): 279-87, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738850
7.
Cutaneous clues to renal cell carcinoma: hereditary leiomyomatosis and renal cell carcinoma.
J Drugs Dermatol
; 12(5): 578-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652956
8.
Prevalence of the metabolic syndrome in children with psoriatic disease.
Pediatr Dermatol
; 30(6): 700-5, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24016334
9.
The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
J Drugs Dermatol
; 9(5): 446-50, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20480786
10.
Association between pediatric psoriasis and the metabolic syndrome.
J Am Acad Dermatol
; 66(6): 1012-3, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22583717
11.
Physician performance measurement: tiered networks and dermatology (an opportunity and a challenge).
J Am Acad Dermatol
; 64(6): 1164-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21571173
12.
Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
J Invest Dermatol
; 124(6): 1275-83, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15955104
13.
Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis.
J Dermatolog Treat
; 24(3): 179-87, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22390688
14.
Management of psoriatic arthritis from the view of the dermatologist.
Nat Rev Rheumatol
; 7(10): 588-98, 2011 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21912431